Santander UK Plc Publication of Supplementary Prospectus (8878E)

TIDMSAN

RNS Number : 8878E

Santander UK Plc

03 March 2020

SANTANDER UK PLC

EUR35,000,000,000 GLOBAL COVERED BOND PROGRAMME

PUBLICATION OF SUPPLEMENTARY PROSPECTUS

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 3 March 2020 to the base prospectus dated 18 April 2019 as supplemented on 30 April 2019, 23 July 2019, 9 August 2019, 30 October 2019 and 30 January 2020 relating to the EUR35,000,000,000 Global Covered Bond Programme of Santander UK plc, unconditionally and irrevocably guaranteed as to payments of interest and principal by Abbey Covered Bonds LLP (the Base Prospectus).

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/8878E_1-2020-3-3.pdf

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM .

The Supplementary Prospectus will also be available for viewing via:

http://www.santander.co.uk/uk/about-santander-uk/debt-investors/santander-uk-covered-bonds

For further information, please contact:

Medium Term Funding

Santander UK plc

2 Triton Square

Regent's Place

London NW1 3AN

Tel: [phone]

Email: [e-mail]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Base Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Base Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Your right to access this service is conditional upon your compliance with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

PSPZXLFBBXLXBBE

(END) Dow Jones Newswires

March 03, 2020 09:38 ET (14:38 GMT)